Search

everythinglearnresearchcommunity

for

Search:↓

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Alopecia areata involves specific immune cells, offering potential treatment targets.

The ZmNF-YC1–ZmAPRG pathway in maize improves phosphorus efficiency and grain yield, suggesting it as a target for breeding better crops.

Keratins are crucial for tissue strength, and mutations in keratin genes can lead to various diseases, highlighting the need for targeted therapies.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Krox20 overexpression in fibroblasts may play a role in abnormal scar formation and could be a target for new treatments.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Autophagy, a cell recycling process, is crucial for prolonged hair growth and could be a potential target for treating hair growth disorders.

Genetic differences in sheep affect wool type, with fat and immune genes influencing hair traits.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Low-dose radiation and certain drugs can inhibit keloid growth, revealing potential treatment targets.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

Ca_v1.2 affects hair growth and could be a target for hair loss treatments.

Let-7b helps alpaca hair grow by reducing TGFβR I protein.

Zfp157 is active in many mouse tissues during development and in specific adult cells.

miR-144 affects hair growth by interacting with Lhx2.

Nephronectin helps attach muscle cells to hair follicles.

Pvalb8 is essential for zebrafish hearing and hair cell development, and its mutation causes hearing loss.

Versican in dermal papilla cells is crucial for healthy hair growth.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Reducing SFRP1 can promote hair growth and may help treat hair loss.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Baby and adult skin cells are different, with baby cells having more active pathways that could help grow new hair follicles.